证券记录 · 已归档季度
EXAS
Exact Sciences Corporation · Healthcare · Medical - Diagnostics & Research
16被追踪持有人
-2Δ持有人
41.47M持有股份
$2.82B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -11.1% ·
股份流向 -1.9% ·
净新建仓位 -12.5%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 1 | -143 | 11.48K | $1.20M | — | −144 |
| Q4 2025 | 146 | +2 | 107.45M | $10.91B | +5 | −2 |
| Q3 2025 | 23 | +1 | 95.08M | $5.20B | +1 | −1 |
| Q2 2025 | 20 | 0 | 105.61M | $5.61B | — | — |
| Q1 2025 | 17 | -2 | 51.51M | $2.23B | +1 | −3 |
| Q4 2024 | 19 | +2 | 51.81M | $2.91B | +3 | −1 |
| Q3 2024 | 16 | -2 | 41.47M | $2.82B | — | −2 |
| Q2 2024 | 18 | — | 42.26M | $1.79B | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 15.84M | -4.0% | $1.08B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 14.33M | -3.1% | $976.31M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.30M | +178.3% | $224.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.30M | +178.3% | $224.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 3.11M | +0.2% | $211.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 3.11M | +0.2% | $211.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.24M | +83.6% | $84.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 1.21M | -15.2% | $82.39M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Norges Bank ✦ (被动) | 680.78K | -45.2% | $46.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 496.30K | 0.0% | $33.81M | 0.0% | Held | 2 | SEC ↗ |
| 20 | Soros Fund Management ✦ | 378.59K | +68.3% | $25.79M | 0.7% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 254.66K | +65.8% | $16.95M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | ARK Investment Management ✦ | 227.44K | -34.0% | $15.49M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 162.42K | +23.5% | $11.06M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 122.90K | -22.8% | $8.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 64.60K | -87.3% | $4.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 42.71K | +6.1% | $2.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 42.71K | +6.1% | $2.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 10.73K | -97.7% | $730,859 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Glenview Capital | $26.59M | 曾为 0.6% |
| Point72 Asset Management | $8.27M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 9 持有人, 64.35K 股份, $4.50M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据